GCP consists of basic and refresher courses that provide essential good clinical practice training for research teams involved in clinical trials of drugs, biologics, and devices, as well as those involved in behavioral intervention and social science research studies. Good Clinical Practice (GCP) is the international ethical, scientific and practical standard to which all clinical research is conducted. It is important that everyone involved in research is trained or appropriately experienced to perform the specific tasks they are being asked to undertake.

 This webinar is intended to help you adequately implement Good Clinical Practices (GCP) including documentation requirements during clinical trials for both drugs and medical devices.

 We recommend that team members leading and delivering research complete, as a minimum, the Introduction to Good Clinical Practice (GCP) course (online or face-to-face). This should be followed by additional specialist courses where appropriate (e.g. Informed Consent) and regular GCP Refresher training.

 In this 180 minutes Instructor led Live webinar, you will have unparalleled opportunities to bring great value and benefits to your organization and to greatly improve your GCPs with increased awareness of the needs - sustainable compliance


Session 1: Good Clinical Practice (GCP) Refresher Training                       
  • 21 CFR 11, Electronic Records / Electronic Signatures
  • 21 CFR Part 50: Protection of Human Subjects – Informed Consent (and IRB’s)
  • 21 CFR Part 54: Financial Disclosure by Clinical Investigators
  • 21 CFR Part 56: Reporting and Recordkeeping requirements
  • 21 CFR Part 312: Investigational New Drug Application
  • 21 CFR Part 314: Application for Approval to Market a New Drug
Break / Q & A
Session 2: ICH E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1),Guidance for Industry – Brief Overview
  • Investigator’s Responsibilities
  • Sponsor’s Responsibilities
  • Monitor’s Responsibilities
  • Audits
  • Protocols / Amendments
  • Essential Documents

Conclusion: Summarization; Q&A 

Who Will Benefit 

  • Clinical Affairs
  • Regulatory Affairs
  • Quality Assurance
  • Research & Development
  • Consultants
  • Contractors/Subcontractors
  • Senior Management
  • Anyone Interested in the Topic
FDA Faculty John E. Lincoln

Faculty John E. Lincoln

Medical Devices / Regulatory Consultant; also pharma and dietary supplements

Saint George, Utah

John E. Lincoln is Principal of J. E. Lincoln and Associates LLC, a consulting company, with over 32 years experience in U.S. FDA-regulated industries, 18 of which as a full time independent FDA-regulated industry consultant. Mr. Lincoln has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS / CGMP audits and problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He’s held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D).

Choose a Purchase Option


Live Webinar - Single Participant

You get one log-in for the live 180-minute webinar for one participant, presentation materials and the opportunity to ask questions by phone and email


Live Group Up to 5 Participants

You get 5 log-in for the live 180-minute webinar for all the participant, presentation materials and the opportunity to ask questions by phone and email


Recorded Access Corporate Group

You'll have 12 month group access to log-in for an archived recording of the entire 180-minute webinar, including the Q&A period . You can log in any time of day or night. You'll also receive all presentation materials, plus an audio recording and transcript for the entire session. Delivery is approximately 48 hours after the session